ANGES Trademark

Trademark Overview


On Thursday, February 8, 2024, a trademark application was filed for ANGES with the United States Patent and Trademark Office. The USPTO has given the ANGES trademark a serial number of 79392447. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, January 10, 2025. This trademark is owned by AnGes, Inc.. The ANGES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations for use in gene therapy

Testing of pharmaceuticals used in genetic engineering, medicine, and gene pharmacology; research and development services relating to genetic engineering, medicines, pharmaceuticals used for gene pharmacology, and the pharmaceutical sciences field
anges

General Information


Serial Number79392447
Word MarkANGES
Filing DateThursday, February 8, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, January 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word "AnGes" or "Anges", where the letters "An" and "es" are black. The letter in the middle is a fusion of a capital letter "G" and a small letter "g" and is made up of two stylized interconnecting ribbons that mimic the double helix structure of double-stranded DNA, where one ribbon is purple and the other is red.
Goods and ServicesPharmaceutical and veterinary preparations for use in gene therapy
Indication of Colors claimedThe color(s) purple, red, and black is/are claimed as a feature of the mark.
Goods and ServicesTesting of pharmaceuticals used in genetic engineering, medicine, and gene pharmacology; research and development services relating to genetic engineering, medicines, pharmaceuticals used for gene pharmacology, and the pharmaceutical sciences field

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAnGes, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, March 28, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 5, 2024APPLICATION FILING RECEIPT MAILED
Monday, September 2, 2024ASSIGNED TO EXAMINER
Tuesday, September 10, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 12, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 12, 2024REFUSAL PROCESSED BY MPU
Monday, October 7, 2024REFUSAL PROCESSED BY IB
Thursday, December 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 10, 2025SUSPENSION LETTER WRITTEN
Friday, January 10, 2025LETTER OF SUSPENSION E-MAILED
Friday, January 10, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED